Introduction Osteoporosis and fragility fracture are more frequently found in systemic lupus erythematosus (SLE) patients than in normal population. This study aims to determine the risk factors in ...

A common medicine used to treat weak bones may also help protect the brain, according to a new large study from researchers at the University of Hong Kong. The study suggests that a group of drugs ...

Finding an effective treatment for osteosarcoma, the most common type of bone cancer in children and young adults, has ...

A research team from the Department of Pharmacology and Pharmacy, LKS Faculty of Medicine of the University of Hong Kong (HKUMed), has found that nitrogen-containing bisphosphonates (NBPs), a ...

Osteoporosis is a common disorder in which bones lose density and become more fragile. Over time, that raises the risk of ...

Some people can take “drug holidays” for years, sometimes, to keep the bone from becoming “frozen” and brittle.

Patients with glucocorticoid-induced osteoporosis on romosozumab show greater gains in lumbar spine bone mineral density than those on denosumab and comparable gains with those on teriparatide.

Adults with osteoporosis who receive denosumab vs bisphosphonates may have a lower long-term risk of developing knee osteoarthritis.

At age 48, I underwent a lumpectomy, chemo and radiation for stage I breast cancer. All is good so far, but I started ...

For the osteoporosis in my hip, I took alendronate for five years, but it did not stop the bone loss. I am now on Prolia, which has helped. I am healthy and fairly active. How lon ...